Full Text View
Tabular View
No Study Results Posted
Related Studies
An Extension Study for Patients Previously Treated With ARQ 501
This study has been completed.
Study NCT00622063   Information provided by ArQule

First Received on February 12, 2008.   Last Updated on February 22, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Interventions listed in this trial
ARQ 501
Additional drug interventions recognized in this trial
Beta-lapachone
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Retroviral Agents
Antiviral Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Reverse Transcriptase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
ArQule


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services